惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Apple Machine Learning Research
Apple Machine Learning Research
J
Java Code Geeks
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Last Week in AI
Last Week in AI
雷峰网
雷峰网
博客园_首页
小众软件
小众软件
美团技术团队
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
腾讯CDC
P
Proofpoint News Feed
MongoDB | Blog
MongoDB | Blog
Google DeepMind News
Google DeepMind News
MyScale Blog
MyScale Blog
U
Unit 42
The Cloudflare Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Microsoft Security Blog
Microsoft Security Blog
大猫的无限游戏
大猫的无限游戏
Engineering at Meta
Engineering at Meta
N
Netflix TechBlog - Medium
Microsoft Azure Blog
Microsoft Azure Blog
博客园 - 叶小钗

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Clariane SE (KRNMF) Q1 2026 Sales/Trading Call Transcript
2026-04-25 · via All Articles on Seeking Alpha

Operator

Welcome to the Clariane First Quarter 2026 Presentation. [Operator Instructions]

Now I will hand the conference over to the management team. Please go ahead.

Grégory Lovichi
Group Chief Financial Officer

Good afternoon, ladies and gentlemen, and thank you for joining Stephane Bisseuil and I today. I'm Gregory Lovichi, Chief Financial Officer of the Clariane Group, and I will present our revenue for the first quarter of 2026 and reiterate our guidance for 2026 as well as the longer-term outlook to 2028.

Before going into the details, let me highlight that this quarter is fully in line with the momentum observed in the second half of last year with solid growth across all our activities and geographies. I will start with the key highlights of the quarter and then walk you through the main drivers contributing to our revenue performance.

Let me start with the key highlights for the quarter on Slide 5. First, we delivered solid organic revenue growth of plus 4.9%, fully in line with our trajectory with all activities contributing. This performance is supported by both volume and pricing effects. In long-term care, occupancy continues to improve with an average rate of 91.7%, up 130 basis points compared to last year. This is an important driver of growth. Alternative Living Solutions also showed strong momentum with organic growth of plus 6.9%.

In Specialty Care, activity is supported by the continued development of outpatient care and management contracts, which are driving volume across all geographies. Second, we have confirmed our access to debt capital markets with a successful issuance of a EUR